| 摘要 |
The present invention relates to combined preparation containing as active substance the following individual components, in the form of a kit-of-parts:monocyte derived cells, particularly cytotoxic macrophages,chemotherapy or immunotherapy drugs,for the simultaneous, separate or sequential use, for the treatment of cancer or infectious diseases. |
